Neogen Corporation (NEOG)
Makes testing kits that detect harmful substances in food and animal feed.
$9.37+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+101.0%
The outlook
Neogen has a "Buy" consensus from analysts, with an average price target sitting roughly 28% above the current price. The stock is trading above both its 50- and 200-day moving averages and sits about 70% of the way through its 52-week range, reflecting a firm uptrend in recent months. Overall sentiment leans bullish based on current technical positioning and analyst outlook.
What’s behind the score
Analyst consensusBuy — 2.3 avg of 3 analysts
Price trendAbove its 50- & 200-day averages
52-week range70% of the way from its 52-week low to high
Price targetAvg target +28% vs current price
Analyst price target
~12-month · 3 analysts$12.00average target+28.1% vs now
Now $9.37
Low $11.00High $13.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.04B
52-wk high
$11.43
52-wk low
$4.56
50-day avg
$9.25
200-day avg
$8.59
Trailing P/E
—